Immunohistochemistry Compared to Cytosol Assays for Determination of Estrogen Receptor and Prediction of the Long-Term Effect of Adjuvant Tamoxifen

Breast Cancer Research and Treatment - Netherlands
doi 10.1007/s10549-010-1202-7
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Estrogen Receptor Regulates E2F1 Expression to Mediate Tamoxifen Resistance

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2010English

Adjuvant Letrozole and Tamoxifen Alone or Sequentially for Postmenopausal Women With Hormone Receptor–Positive Breast Cancer: Long-Term Follow-Up of the BIG 1-98 Trial

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2019English

Experimental Studies on Hepatocarcinogenesis Induced by Oral Contraceptives, With Special Reference to Estrogen Receptor and the Effect of Tamoxifen.

Acta Hepatologica Japonica
Hepatology
1987English

Reversible Disaggregation of the Cytosol-Estrogen Binding Protein of Uterine Cytosol.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1968English

Estrogenicity of Styrene Oligomers and Assessment of Estrogen Receptor Binding Assays

Environmental Health Perspectives
MutagenesisPublic HealthEnvironmentalHealthToxicologyOccupational Health
2002English

Development of New Estrogen Receptor-Targeting Therapeutic Agents for Tamoxifen-Resistant Breast Cancer

Future Medicinal Chemistry
Drug DiscoveryMolecular MedicinePharmacology
2013English

Nogo-B Receptor Increases the Resistance to Tamoxifen in Estrogen Receptor-Positive Breast Cancer Cells

Breast Cancer Research
Cancer ResearchOncology
2018English

Side Effects of Adjuvant Tamoxifen.

BMJ
1991English

Duration of Adjuvant Tamoxifen Treatment

Breast Cancer Research
Cancer ResearchOncology
2001English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy